Cargando…

Comparing the Effect of Two Low-dose and High-dose Four-drug Regimens of Furazolidone in Eradicating Helicobacter Pylori

BACKGROUND Antibiotic resistance is a major cause of Helicobacter pylori (H. pylori ) treatment failures. The increased resistance to clarithromycin and metronidazole has reduced the ability of this therapeutic regimen and prompted researchers to look for other drugs. One of the antibiotics of inter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seyedmajidi, Mohammad Reza, Hosseini, Seyed Ashkan, Vafaeimanesh, Jamshid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iranian Association of Gastroerterology and Hepatology 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531922/ https://www.ncbi.nlm.nih.gov/pubmed/34712451 http://dx.doi.org/10.34172/mejdd.2021.216

Ejemplares similares

Comparison of quadruple and triple Furazolidone containing regimens on eradication of helicobacter pylori
por: Mokhtare, Marjan, et al.
Publicado: (2015)

Low Dose Furazolidone for Eradication of Helicobacter pylori Instead of Clarithromycin: A Clinical Trial
por: Hajaghamohammadi, Aliakbar, et al.
Publicado: (2015)

Levofloxacin-containing triple therapy versus bismuth-based quadruple therapy as regimens for second line anti- Helicobacter pylori
por: Seyyedmajidi, Mohamadreza, et al.
Publicado: (2019)

Efficacy and safety of bismuth quadruple regimens containing tetracycline or furazolidone for initial eradication of Helicobacter pylori
por: Wang, Junxian, et al.
Publicado: (2021)

Comparison of Helicobacter pylori eradication regimens in patients with end stage renal disease
por: Seyyed Majidi, Mohammadreza, et al.
Publicado: (2018)

A Comparison between Moderate- and High-dose Furazolidone in Triple Regimens for Helicobacterpylori Eradication in Iran
por: Hosseini, Vahid, et al.
Publicado: (2014)

Comparison of Azithromycin and Clarithromycin Triple Therapy Regimens for Helicobacter Pylori Eradication in Hemodialysis Patients
por: Jalalzadeh, Mojgan, et al.
Publicado: (2012)

Addition of cranberry to proton pump inhibitor-based triple therapy for Helicobacter pylori eradication
por: Seyyedmajidi, Mohammadreza, et al.
Publicado: (2016)

Furazolidone and Helicobacter pylori Treatment
por: Talebi Bezmin Abadi, Amin
Publicado: (2015)

Short-Duration Furazolidone Therapy in Combination with Amoxicillin, Bismuth Subcitrate, and Omeprazole for Eradication of Helicobacter pylori
por: Hasan, Salman R., et al.
Publicado: (2010)

The efficacy and safety of furazolidone-bismuth quadruple therapy for Helicobacter pylori eradication with or without probiotic supplementation
por: Noorbakhsh, Nafeh, et al.
Publicado: (2022)

Resistance of Helicobacter pylori to furazolidone and levofloxacin: A viewpoint
por: Zamani, Mohammad, et al.
Publicado: (2017)

Outcomes of furazolidone- and amoxicillin-based quadruple therapy for Helicobacter pylori infection and predictors of failed eradication
por: Zhang, Ya-Wen, et al.
Publicado: (2018)

Efficacy of a 7-day course of furazolidone, levofloxacin, and lansoprazole after failed Helicobacter pylori eradication
por: Eisig, Jaime N, et al.
Publicado: (2009)

Safety of furazolidone-containing regimen in Helicobacter pylori infection: a systematic review and meta-analysis
por: Ji, Chao-ran, et al.
Publicado: (2020)

Adding diclofenac to Helicobacter pylori eradication regimen
por: Emami, Mohammad Hasan, et al.
Publicado: (2015)

Comparison of half-dose and full-dose triple therapy regimens for Helicobacter pylori eradication in patients with end-stage renal disease
por: Ehsani Ardakani, Mohammad Javad, et al.
Publicado: (2014)

Hybrid Therapy Regimen for Helicobacter Pylori Eradication
por: Song, Zhi-Qiang, et al.
Publicado: (2016)

Helicobacter pylori infection prevalence: Is it different in diabetics and nondiabetics?
por: Vafaeimanesh, Jamshid, et al.
Publicado: (2015)

Comparison of the Dual Therapy of Ilaprazole-Amoxicillin and the Bismuth Quadruple Therapy of Ilaprazole-Amoxicillin-Furazolidone-Bismuth Glycyrrhizinate for Eradication of Helicobacter pylori
por: Niu, Min, et al.
Publicado: (2022)

Addition of clidinium-C to the 14-day proton-pump inhibitor-based triple therapy for Helicobacter pylori eradication
por: Seyyedmajidi, Mohammadreza, et al.
Publicado: (2016)

Efficacy and tolerability of fourteen-day sequential quadruple regimen: pantoprazole, bismuth, amoxicillin, metronidazole and or furazolidone as first-line therapy for eradication of Helicobacter pylori: a randomized, double-blind clinical trial
por: Mansour-Ghanaei, Fariborz, et al.
Publicado: (2019)

Furazolidone-based Therapies for Helicobacter pylori Infection: A Pooled-data Analysis
por: Zullo, Angelo, et al.
Publicado: (2012)

Furazolidone-induced pulmonary toxicity in Helicobacter pylori infection: Two case reports
por: Ye, Yao, et al.
Publicado: (2023)

Efficacy of Clarithromycin Containing Bismuth–Based Regimen as a Second-Line Therapy in Helicobacter Pylori Eradication
por: Mokhtare, Marjan, et al.
Publicado: (2015)

A Comparison between Hybrid and Concomitant Regimens for Helicobacter Pylori Eradication: A Randomized Clinical Trial
por: Alhooei, Saman, et al.
Publicado: (2016)

Effect of Helicobacter pylori on metabolic syndrome parameters in diabetic patients
por: Vafaeimanesh, Jamshid, et al.
Publicado: (2016)

Helicobacter pylori Infection and Insulin Resistance in Diabetic and Nondiabetic Population
por: Vafaeimanesh, Jamshid, et al.
Publicado: (2014)

Eradication of Helicobacter pylori in Children by Triple Therapy Regimens of Amoxicillin, Omeprazole, and Clarithromycin or Azithromycin
por: Esmaeili-Dooki, Mohammad Reza, et al.
Publicado: (2015)

Rifabutin and Furazolidone Could Be the Candidates of the Rescue Regimen for Antibiotic-Resistant H. pylori in Korea
por: Choi, Youn I, et al.
Publicado: (2019)

Effectiveness and Safety of Rifaximin-Containing Regimens for Helicobacter pylori Eradication: Systematic Review – Are They Potential Eradication Regimens?
por: Wang, Yu, et al.
Publicado: (2022)

Treatment with compound Lactobacillus acidophilus followed by a tetracycline- and furazolidone-containing quadruple regimen as a rescue therapy for Helicobacter pylori infection
por: Liu, Airu, et al.
Publicado: (2020)

Association of Helicobacter pylori Infection with Coronary Artery Disease: Is Helicobacter pylori a Risk Factor?
por: Vafaeimanesh, Jamshid, et al.
Publicado: (2014)

Effect of Helicobacter pylori Infection on Serum Lipid Profile
por: Haeri, Mohamadreza, et al.
Publicado: (2018)

Comparative Effectiveness of Various Eradication Regimens for Helicobacter Pylori Infection in the Northeastern Region of Poland
por: Wasielica-Berger, Justyna, et al.
Publicado: (2022)

Meta-analysis: High-dose vs. low-dose metronidazole-containing therapies for Helicobacter pylori eradication treatment
por: Ji, Yingjie, et al.
Publicado: (2018)

Efficacy of Two Triple Eradication Regimens in Children with Helicobacter pylori Infection
por: Choi, Jungi, et al.
Publicado: (2006)

“Concomitant” or “sequential” eradication of Helicobacter pylori: which regimen comes first?
por: Georgopoulos, Sotirios D.
Publicado: (2014)

Rifaximin Plus Levofloxacin-Based Rescue Regimen for the Eradication of Helicobacter pylori
por: Yun, Sang-Pil, et al.
Publicado: (2012)

Effects of 14-days bismuth- and tetracycline-containing quadruple therapy with concomitant regimen for the first line Helicobacter pylori eradication
por: Kazemi Veysari, Arash, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gjvdc91cumaudk9ofrqvdd8nq9